Literature DB >> 27153500

MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb.

Changchun Xiao, Dinis Pedro Calado, Gunther Galler, To-Ha Thai, Heide Christine Patterson, Jing Wang, Nikolaus Rajewsky, Timothy P Bender, Klaus Rajewsky.   

Abstract

Entities:  

Year:  2016        PMID： 27153500     DOI： 10.1016/j.cell.2016.04.056

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  8 in total

Review 1.  Beyond mRNA: The role of non-coding RNAs in normal and aberrant hematopoiesis.

Authors:  Mark C Wilkes; Claire E Repellin; Kathleen M Sakamoto
Journal:  Mol Genet Metab       Date:  2017-07-25       Impact factor: 4.797

2.  MicroRNA-126 deficiency enhanced the activation and function of CD4+ T cells by elevating IRS-1 pathway.

Authors:  F Chu; Y Hu; Y Zhou; M Guo; J Lu; W Zheng; H Xu; J Zhao; L Xu
Journal:  Clin Exp Immunol       Date:  2017-10-30       Impact factor: 4.330

Review 3.  Angiogenic Exosome-Derived microRNAs: Emerging Roles in Cardiovascular Disease.

Authors:  Tian-Rong Zhang; Wei-Qiang Huang
Journal:  J Cardiovasc Transl Res       Date:  2020-10-26       Impact factor: 4.132

4.  Ruxolitinib Ameliorates Airway Hyperresponsiveness and Lung Inflammation in a Corticosteroid-Resistant Murine Model of Severe Asthma.

Authors:  Hariharan Subramanian; Tanwir Hashem; Devika Bahal; Ananth K Kammala; Kanedra Thaxton; Rupali Das
Journal:  Front Immunol       Date:  2021-10-29       Impact factor: 7.561

Review 5.  Epigenetic regulation of hematopoietic stem cell homeostasis.

Authors:  Penglei Jiang; Hui Wang; Jiachen Zheng; Yingli Han; He Huang; Pengxu Qian
Journal:  Blood Sci       Date:  2019-09-17

6.  LNCRNA XIST Inhibits miR-377-3p to Hinder Th17 Cell Differentiation through Upregulating ETS1.

Authors:  Chen Yao; Chao Li; Zhijia Liu; Li Xiao; Hongwei Bai; Bingyi Shi
Journal:  Comput Intell Neurosci       Date:  2022-06-14

Review 7.  Altered expression of microRNAs and B lymphocytes during Natalizumab therapy in multiple sclerosis.

Authors:  André Eduardo de Almeida Franzoi; Fernanda Subtil de Moraes Machado; Washigton Luiz Gomes de Medeiros Junior; Isabelle Pastor Bandeira; Wesley Nogueira Brandão; Marcus Vinicius Magno Gonçalves
Journal:  Heliyon       Date:  2021-06-09

8.  LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration.

Authors:  Junjun Luan; Jingqi Fu; Chengjie Chen; Congcong Jiao; Weiwei Kong; Yixiao Zhang; Qing Chang; Yanqiu Wang; Detian Li; Gabor G Illei; Jeffrey B Kopp; Jingbo Pi; Hua Zhou
Journal:  Arthritis Res Ther       Date:  2019-12-11       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.